医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Mevion Signs Agreement to Develop Proton Center in Tianjin, China

2019年11月12日 PM11:00
このエントリーをはてなブックマークに追加


 

LITTLETON, Mass.

Mevion Medical Systems has signed an agreement with Tianjin Port Free Trade Zone Administrative Committee and Tianyi Holdings to develop a proton therapy center in the rapidly growing research and development hub, the Tianjin Airport Economic Area. The agreement was signed at the China International Import Expo.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191112005325/en/

Joint signing ceremony for the agreement: (from left to right) Fuju Zhang, Vice President, China at Mevion Medical Systems, Tiancheng You, Director of Tianjin Port Free Trade Zone Administrative Committee and Peng Zhou, Vice President of Tianyi Holdings Ltd. Co. signed the agreement on behalf of the three parties. (Photo: Business Wire)

Joint signing ceremony for the agreement: (from left to right) Fuju Zhang, Vice President, China at Mevion Medical Systems, Tiancheng You, Director of Tianjin Port Free Trade Zone Administrative Committee and Peng Zhou, Vice President of Tianyi Holdings Ltd. Co. signed the agreement on behalf of the three parties. (Photo: Business Wire)

Under the agreement, the three parties will partner to develop a state-of-the-art proton therapy center to bring advanced healthcare services to Tianjin and its surrounding areas. In addition to clinical services, the Tianjin center will also pursue research activities to advance proton therapy.

The Tianjin Airport Economic Area was founded in 2015 to be a free trade hub supporting research and development of next-generation life sciences, aerospace technologies, and high-tech manufacturing.

About Mevion Medical Systems

Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and China. For more information, please visit www.mevion.com

Follow us on Twitter: @MevionMedical
Connect with us on LinkedIn: Mevion Medical Systems
Like Us on Facebook: MevionMedical

View source version on businesswire.com: https://www.businesswire.com/news/home/20191112005325/en/

CONTACT

Melanie Benton

Mevion Medical Systems

Mbenton@mevion.com 1-978-540-1551

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 武田通过与Moderna和日本政府合作,在日本扩大COVID-19疫苗供货
  • ABEC将向百因诺生物交付业内首台6000L一次性生物反应器
  • Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia
  • The McQuade Center for Strategic Research and Development Enters Collaboration Agreement with Rugen Holdings (Cayman) Limited to Develop Novel Treatment for Patients with Diverse Psychiatric Disorders
  • 国連世界都市デーを機に、G20のアーバン20(U20)エンゲージメント・グループがCOVID-19を受けて「世界都市強靭性基金」の創設を発表